In summary, the present study clearly demonstrates that leptin induces fatty acid metabolic changes in breast cancer cells, which are characterized by a concomitant increase in FAO and FAS, and further provides the first evidence that autophagy activation drives this fatty acid metabolic reprogramming (Fig. 7). The gene discussed is LEP; the disease is breast carcinoma.